Interventional Stroke Management in a Patient With COVID-19

In patients with COVID-19, acute stroke management may need to be limited to patients with viable outcomes, perhaps younger population with fewer comorbidities, and patients without respiratory failure requiring mechanical ventilation. Protecting healthcare professionals must be kept at the forefront if aggressive stroke treatment is used.

Automated summary

In patients with COVID-19, acute stroke management may need to be limited to patients with viable outcomes, potentially younger population with fewer comorbidities, and patients without respiratory failure requiring mechanical ventilation. Protecting healthcare professionals must be prioritized if aggressive stroke treatment is utilized.